An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
Trial ID or NCT#
This large, non-randomized observational study is being conducted to provide data about the impact of ethnic origin on outcomes and resource utilization during the 2nd line treatment of non-small cell lung cancer (NSCLC) in a routine medical care setting.
Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients Being Treated Second Line With Pemetrexed - An Observational Study
- - Non-small cell lung cancer (NSCLC) (any histologic type) - Stage IIIB or IV disease - Should have had 1 line of chemotherapy for Metastatic disease - Adequate hematologic, hepatic and renal function - Measurable or evaluable disease
- - Pregnant or lactating females
Contact us to find out if this trial is right for you.
Cancer Clinical Trials Office
View on ClinicalTrials.gov